Evidence map›Paper›PMID 39958973›Full record

ArticleJournal of extracellular biology2025

Comparison of Methods for Isolation and Characterization of Total and Astrocyte-Enriched Extracellular Vesicles From Human Serum and Plasma.

Leandra K Figueroa-Hall, Kaiping Burrows, Ahlam M Alarbi, Bethany N Hannafon, Cole Hladik, Chibing Tan, Rajagopal Ramesh, Jennifer L Stewart, Victoria B Risbrough, Martin P Paulus and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of extracellular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07651787 (Neurovascular and Mitochondrial Mechanisms of Transcranial Photobiomodulation in Vascular Mild Cognitive Impairment), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07651787 narecruitingnot on this map

Neurovascular and Mitochondrial Mechanisms of Transcranial Photobiomodulation in Vascular Mild Cognitive Impairment

TypeinterventionalSponsorUniversity of OklahomaRan2025 to 2026Enrolled40ConditionsMild Cognitive Impairment (MCI), Amyloid PathologyArmsActive Vielight Neuro RX-Duo device -Active transcranial photobiomodulation, Sham Vielight Neuro RX-Duo device -Sham transcranial photobiomodulation
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Leandra K Figueroa-HallLaureate Institute for Brain Research Tulsa Oklahoma USA.ORCID https://orcid.org/0000-0003-1898-9868
Kaiping BurrowsLaureate Institute for Brain Research Tulsa Oklahoma USA.
Ahlam M AlarbiIntegrative Immunology Center University of Oklahoma (OU) Tulsa Oklahoma USA.
Bethany N HannafonDepartment of Obstetrics and Gynecology OU Health Sciences Center (OUHSC) Oklahoma City Oklahoma USA.
Cole HladikDepartment of Obstetrics and Gynecology OU Health Sciences Center (OUHSC) Oklahoma City Oklahoma USA.
Chibing TanIntegrative Immunology Center University of Oklahoma (OU) Tulsa Oklahoma USA.
Rajagopal RameshOU Health Stephenson Cancer Center Oklahoma City Oklahoma USA.ORCID https://orcid.org/0000-0002-7658-5338
Jennifer L StewartLaureate Institute for Brain Research Tulsa Oklahoma USA.
Victoria B RisbroughVA Center of Excellence for Stress and Mental Health La Jolla California USA.
Martin P PaulusLaureate Institute for Brain Research Tulsa Oklahoma USA.
T Kent TeagueIntegrative Immunology Center University of Oklahoma (OU) Tulsa Oklahoma USA.

Funding

The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)P20GM121312 · NIGMS · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI MARTIN P. PAULUS · 2017 to 2026
$23.7M
The Impact of Maternal Adversity and Attachment Security on Infant Stress Reactivity: Prenatal Epigenetic PathwaysP20GM109097 · NIGMS · OSU CENTER FOR HEALTH SCIENCES · PI Dian Yu · 2016 to 2026
$22.8M
Plasticity of Aversive Salience in Opioid Use DisorderR01DA050677 · NIDA · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI STEWART, JENNIFER LORRAINE · 2021 to 2025
$3.0M
Exosomes as carriers of cancer therapeuticsR01CA254192 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RAMESH, RAJAGOPAL · 2021 to 2025
$2.8M
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome CargoRF1AG079303 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RISBROUGH, VICTORIA B, RISSMAN, ROBERT · 2023 to 2023
$1.9M
In vivo inflammatory challenge to elucidate the role of the toll-like receptor 4 pathway in depressionR00MH126950 · NIMH · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI Leandra Kali Figueroa-Hall · 2024 to 2026
$737k
BLRD VA IK6 BX006186CSRD VA IK2 CX002343NCI NIH HHS R01 CA254192NIA NIH HHS RF1 AG079303NIDA NIH HHS R01 DA050677NIGMS NIH HHS P20 GM109097NIGMS NIH HHS P20 GM121312NIMH NIH HHS L30 MH131119NIMH NIH HHS R00 MH126950
6 · The paper itself

Abstract

Extracellular vesicles (EV) which play critical roles in intercellular communication, have garnered interest as biomarkers with researchers studying brain-related disease processes due to their ability to be isolated from various biofluids. Astrocytes, a type of glial cell, play a critical role in neuronal regulation and function. As such, EV enriched from astrocytes can be used to interrogate cargo and identify mechanisms by which astrocytes communicate with other cells of the central nervous system or shed light on pathophysiological conditions. This manuscript compared five EV isolation methods (differential ultracentrifugation [dUC], precipitation, precipitation + purification, silicon carbon resin and size exclusion chromatography [SEC]) using small volumes of human plasma and serum with a focus on immunocapture of astrocyte-enriched EV (AEEV), with the excitatory amino acid transporter 1, or GLAST. Methods were evaluated on yield, purity, recovery and downstream application to include immunoassays for tetraspanin, immune and astrocyte markers. Results revealed that whilst precipitation-based methods such as ExoQuick yielded higher EV concentrations, size exclusion (SmartSEC, qEV) provided greater purity, emphasizing a trade-off between yield and purity. This study provides a comprehensive resource for researchers in selecting EV isolation methods tailored to small biobanked clinical samples, with the goal of advancing biomarker discovery in Neuroscience.

Indexed as

astrocyte‐enriched extracellular vesiclesdifferential centrifugationextracellular vesiclesprecipitationprecipitation + purificationresin‐separating matrixsize exclusion

Identifiers

PMID39958973
PMCPMC11826443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.